You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Suppliers and packagers for generic pharmaceutical drug: FLUOCINONIDE


✉ Email this page to a colleague

« Back to Dashboard


FLUOCINONIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Amneal FLUOCINONIDE fluocinonide CREAM;TOPICAL 210554 ANDA A-S Medication Solutions 50090-6309-0 1 TUBE in 1 CARTON (50090-6309-0) / 30 g in 1 TUBE 2017-10-01
Amneal FLUOCINONIDE fluocinonide CREAM;TOPICAL 210554 ANDA A-S Medication Solutions 50090-7923-0 1 TUBE in 1 CARTON (50090-7923-0) / 15 g in 1 TUBE 2017-10-01
Amneal FLUOCINONIDE fluocinonide CREAM;TOPICAL 210554 ANDA Preferred Pharmaceuticals Inc. 68788-8105-3 1 TUBE in 1 CARTON (68788-8105-3) / 30 g in 1 TUBE 2021-11-03
Amneal FLUOCINONIDE fluocinonide CREAM;TOPICAL 210554 ANDA Amneal Pharmaceuticals NY LLC 69238-1534-2 1 TUBE in 1 CARTON (69238-1534-2) / 120 g in 1 TUBE 2017-10-01
Amneal FLUOCINONIDE fluocinonide CREAM;TOPICAL 210554 ANDA Amneal Pharmaceuticals NY LLC 69238-1534-3 1 TUBE in 1 CARTON (69238-1534-3) / 30 g in 1 TUBE 2017-10-01
Amneal FLUOCINONIDE fluocinonide CREAM;TOPICAL 210554 ANDA Amneal Pharmaceuticals NY LLC 69238-1534-5 1 TUBE in 1 CARTON (69238-1534-5) / 15 g in 1 TUBE 2017-10-01
Amneal FLUOCINONIDE fluocinonide CREAM;TOPICAL 210554 ANDA Amneal Pharmaceuticals NY LLC 69238-1534-6 1 TUBE in 1 CARTON (69238-1534-6) / 60 g in 1 TUBE 2017-10-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Fluocinonide

Last updated: February 19, 2026

Who are the leading suppliers of fluocinonide?

Fluocinonide, a potent topical corticosteroid, is manufactured by several pharmaceutical companies. The market comprises both brand-name and generic manufacturers, with products distributed globally. Key suppliers include:

  • Pfizer Inc. (brand: Lidex)
  • Mylan N.V. (generic formulations)
  • Sun Pharmaceutical Industries Ltd.
  • Taro Pharmaceuticals Inc.
  • Sandoz (a Novartis division)
  • Lupin Limited

These companies supply fluocinonide in various formulations, including creams, ointments, gels, and solutions.

Market Segmentation and Product Formulations

Company Product Name Formulations Available Market Regions
Pfizer Lidex Cream, ointment North America, select international markets
Mylan Generic fluocinonide Cream, gel Global
Sun Pharma Fluocinonide Gel Gel India, Southeast Asia
Taro Taro Fluocinonide Cream, ointment US, Canada
Sandoz Fluocinonide Sandoz Cream, ointment Europe, US
Lupin Lupin Fluocinonide Cream, gel India, Middle East, Africa

Distribution Channels

Suppliers distribute fluocinonide through:

  • Wholesale distributors: Provide drug wholesalers and clinics.
  • Direct sales: To hospitals and healthcare providers.
  • Online platforms: For certain generic products, particularly in regions with e-prescription regulations.

Regulatory Approvals and Manufacturing Locations

Major manufacturers operate manufacturing facilities in:

  • United States (Pfizer, Taro, Sandoz)
  • India (Sun Pharma, Lupin, Lupin)
  • Europe (Sandoz)
  • Manufacturing compliant with US FDA and EMA standards.

Product approval timelines vary by region, with US FDA approvals dating back to early 2000s for several brands and generics.

Market Trends and Supply Dynamics

  • Increasing demand due to topical corticosteroid prescriptions for conditions like psoriasis, dermatitis.
  • Growth in generic drug manufacturing, reducing prices and increasing supply.
  • Supply chain disruptions occasionally occur due to manufacturing or regulatory delays, affecting availability in some regions.

Key Notes for Stakeholders

  • Pfizer's Lidex remains a prominent brand in North America.
  • Generics from Mylan, Sun Pharma, Lupin, Taro, and Sandoz dominate global markets.
  • Formulation variety supports diverse consumer needs and regional preferences.

References

[1] U.S. Food and Drug Administration. (2022). Drug Applications and Approvals. https://www.fda.gov [2] IQVIA. (2022). Global Pharmaceutical Market Data. https://www.iqvia.com [3] GlobalData. (2021). Top Suppliers of Topical Corticosteroids. https://www.globaldata.com [4] European Medicines Agency. (2022). Marketing Authorisations. https://www.ema.europa.eu

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing